Replies to post #4162 on Enanta Pharmaceuticals Inc (ENTA)

[alertmeipp]

They had two calls for PED and challenge data and then attended the JPM in last few months - still the investment case is just not getting across.

RSV data got treated as negative I think mainly because they can’t seems to get partnership done for anything after myrovet